What are the potential complications of Henoch-Schönlein Purpura (HSP) in a pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Complications of Henoch-Schönlein Purpura in Pediatric Patients

Renal involvement is the most critical complication of HSP, occurring in 20-54% of children and representing the primary determinant of long-term morbidity and mortality. 1, 2

Renal Complications

Nephritis is the most important prognostic factor and can range from mild hematuria to severe crescentic glomerulonephritis with renal failure. 1, 2

  • Mild manifestations include microscopic hematuria and mild proteinuria, which are common and typically self-limited 1
  • Severe presentations include nephrotic-range proteinuria, acute kidney injury with elevated creatinine, and crescentic glomerulonephritis affecting up to 75% of glomeruli 3
  • Long-term sequelae include persistent hypertension and end-stage kidney disease, though these are rare 1
  • Pregnancy complications occur in women with childhood HSP history, including proteinuria and hypertension requiring close monitoring 2

Gastrointestinal Complications

Severe GI bleeding can occur and may require blood transfusions, with bleeding potentially originating from sites throughout the GI tract. 3

  • Common manifestations include diffuse abdominal pain, gastritis, duodenitis, ileitis, and ulceration 3, 1
  • Intussusception is a recognized complication requiring surgical evaluation 1
  • Severe hemorrhage from the terminal ileum near Meckel's diverticulum has been reported, presenting with acute anemia (hemoglobin dropping to 3.5 g/dL) and positive fecal occult blood 3
  • GI bleeding typically responds to symptomatic management and blood transfusions when severe 3

Cardiac Complications (Rare but Serious)

Cardiac involvement is exceptionally rare but carries a poor prognosis when present, requiring immediate recognition and treatment. 3, 4

  • Arrhythmias including atrial fibrillation and non-sustained ventricular tachycardia can occur secondary to cardiac vasculitis 3
  • Severe mitral regurgitation has been documented in children with HSP 4
  • Treatment requires anti-arrhythmic drugs (metoprolol, amiodarone) and intensification of immunosuppressive therapy 3
  • Cardiac involvement may be more common than previously recognized and indicates severe vasculitis 4

Pulmonary Complications (Rare but Life-Threatening)

Pulmonary hemorrhage is a rare complication that significantly increases morbidity and mortality and generally indicates severe vasculitis. 4

  • Clinical significance: When present, pulmonary hemorrhage dramatically worsens prognosis 4
  • Association: Often occurs in conjunction with other severe complications like cardiac involvement 4

Neurological Complications (Uncommon)

Neurological manifestations can develop weeks after initial presentation and require prompt recognition. 3

  • Clinical findings include proximal muscle weakness, tremors, and upper and lower extremity clonus 3
  • Timing: May present 7 weeks or more after initial treatment 3
  • Management: Requires intensification of immunosuppressive therapy with agents like cyclophosphamide 3

Musculoskeletal Complications

Arthritis or arthralgia affects multiple joints and is part of the diagnostic criteria. 1, 5

  • Presentation: Joint pain and swelling, particularly in lower extremities 3, 1
  • Course: Typically self-limited and resolves without long-term sequelae 1

Clinical Monitoring Algorithm

All children with HSP require follow-up for at least 6 months with specific surveillance parameters. 2

  • Regular urine testing for proteinuria and hematuria at each visit 2
  • Blood pressure measurement at every follow-up to detect hypertension 2
  • Renal function monitoring with BUN and creatinine when nephritis is present 3
  • Cardiac evaluation with EKG and telemetry if palpitations, syncope, or dizziness develop 3
  • Immediate evaluation for acute anemia, severe abdominal pain, or neurological symptoms 3

Important Caveats

Adolescents may experience more severe presentations compared to younger children and require closer monitoring for all complications. 3

The average disease duration is 4 weeks, but complications can develop at any point during or after the acute illness, necessitating prolonged surveillance. 1

Early steroid treatment does not reduce the incidence or severity of nephropathy, though corticosteroids may be beneficial for severe GI pain and hemorrhage. 1

References

1
Research

Henoch-Schönlein Purpura in Children: An Updated Review.

Current pediatric reviews, 2020

5
Research

Henoch-Schönlein purpura: four cases and a review.

The Journal of emergency medicine, 1994

Related Questions

Who should I consult for Henoch-Schönlein Purpura (HSP) rash?
What management is recommended for a 7-year-old child with a history of Henoch-Schönlein purpura (HSP) and persistent trace proteinuria?
What is the approach to diagnosis and management of Henoch-Schonlein purpura (HSP) in a pediatric patient, likely between 3-10 years old, presenting with suspected HSP?
What warning signs in a patient diagnosed with Henoch-Schönlein Purpura (HSP) require immediate medical attention?
What is the diagnosis and recommended management for a previously healthy 14-year-old male presenting with bilateral lower‑extremity palpable purpura, fever, and gastrointestinal bleeding?
What treatment approach would you recommend for a 43-year-old female patient with major depressive disorder, anxiety, and attention deficit hyperactivity disorder (ADHD), who has a history of intolerance to stimulants due to suicidal ideation, and is currently taking [MEDICATION] (sertraline) 50 mg, with significant financial stressors and potential hormonal imbalances?
Does Jascayd (generic name) negatively affect the immune system in patients with autoimmune disease or those who have undergone organ transplantation?
What are the treatment options for candidiasis (fungal infection) of the skin in patients with or without underlying medical conditions or compromised immune systems?
What is the recommended empiric antibiotic regimen for a patient with End-Stage Renal Disease (ESRD) and suspected pneumonia?
What are the next steps for a patient with a subcutaneous soft mass on the chest wall, shown as an ovoid hypoechoic (having low echo intensity)/hyperemic (increased blood flow) mass on ultrasound, with a non-specific appearance suggestive of either an organizing hematoma or a small lymph node?
What is the recommended course of action for a patient over 50 years old who received the first dose of the shingles vaccine (zoster vaccine) and missed the second dose?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.